GlassScriptPhysician profile
Melissa L Dezoute
NPI 1669814349
$1,403.22
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.96 · 2022: $505 · 2023: $521 · 2024: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $883.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $882.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $315.05 | 2022-2024 | Myrbetriq |
| Sumitomo Pharma America, INC. | $220.31 | 2024 | Gemtesa |
| Teleflex LLC | $191.05 | 2021-2024 | Urolift |
| Boston Scientific Corporation | $155.53 | 2022-2024 | Rezum Generator, Tria Firm |
| Coloplast Corp | $123.13 | 2022-2023 | Speedicath |
| Convatec INC. | $114.35 | 2022-2023 | |
| 180 Medical, INC. | $47.35 | 2022-2023 | Gentlecath Glide |
| Hollister Incorporated | $41.23 | 2023 | Infyna Chic, Onli, Vapro |
| Tolmar, INC. | $38.42 | 2023-2024 | |
| Amgen INC. | $27.56 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.11 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $23.18 | 2022 | |
| Accord Healthcare, INC. | $21.27 | 2023 | |
| Endo Pharmaceuticals INC. | $18.78 | 2023 | Xiaflex |
| Halozyme INC | $15.14 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Ih INC. | $13.82 | 2022 | |
| Blue Earth Diagnostics | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Dezoute listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.